Bibliography
- HABIBH W, KHANKARIK R, HONTZ J: Fast-dissolve drug delivery system. Crit. Rev. Ther. Drug Carrier Syst. (2000) 17:61-72.
- LOYD A: Flavors and flavoring. Int. J. Pharm. Compounding (1997) 1:90-92.
- SEAGER H: Drug-deliver Products and the zydis fast-dissolving dosage form. J. Pharm. Pharmacol. (1998) 50:375-382.
- CHANG RK, GUO X, BURNSIDE B, COUCH R: Fast-dissolving tablets, Pharm. Technol. (2000) 24:52-58.
- PROULX SM, MELCHIORREM HA: New dosage forms lead to confusion. US Pharm. (2001) 26:68-70.
- SMITH AJ, MORAN J, DANGLER LV, LEIGHT RS, ADDY M: The efficacy of an anti-gingivitis chewing gum. J. Clin. Periodontol. (1996) 23:19-21.
- HYRUP B, Andresen C, Andreasen LV, Tandrup B, Christensen T: The MediChew® technology platform. Expert Opin. Drug. Deliv. (2005) 2:927-933.
- KAWASHIMA Y, NIWA T, HANDA T, TAKEUSHI H, IWAMOTO T, ITOH K: Preparation of controlled-released microspheres of ibuprofen with acrylic polymers by a novel quasiemulsion solvent diffusion method. J. Pharm. Sci. (1989A) 78:68-72.
- KAWASHIMA Y, NIWA T, HANDA T, TAKEUSHI H, IWAMOTO T, ITOH K: Preparation of prolonged-released spherical micromatrix of ibuprofen with acrylic polymer by the emulsion-solvent diffusion method for improving bioavailability. Chem. Pharm. Bull. (1989B) 37:425-429.
- SJOQVISTS R, GRAFFEER C, EKMAN J: In vitro validation of the release rate and paratability of remoxipride-modified release suspension. Pharm. Res. (1993) 10:1020-1030.
- GOUIN S: Microencapsulation: industrial appraisal of existing technologies and trends. Trends Food Sci. Technol. (2004) 15:330-347.
- NII T, ISHII F: Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int. J. Pharm. (2005) 298:198-205.
- YAN G, FU-DE, YING G, LEI Y, YONG-SHENGY W, LI-NA Z: Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking: Int. J. Pharm. (2006) 318:62-69.
- QI S, DEUTSCH D, CRAIQ DQ: An investigation into the interaction between taste masking fatty acid microspheres and alkaline buffer using thermal and spectroscopic analysis. Pharm. Sci. (2006) 95:1022-1028.
- FUNASAKI N, KAWAGUCHI R, HADA S, NEYAN S: Ultraviolet spectroscopicestimation of microenvironments and bitter tastes of oxyphenonium bromide in cyclodextrin solutions. J. Pharm. Sci. (1999) 88:759-762.
- CHALLA R, AHUJA A, ALI J, KHAR RK: Cyclodextrins in drug delivery: an updated review. AAPS Pharm. Sci. Tech. (2005) 6:E329-E357.
- SZEJTLI J: Cyclodextrin Technology. Kluwer Academic Publishers: Dordrecht, The Netherlands (1988): Chapters 3 and 7.
- FRÖMMING K.H, SZEJTLI J: Cyclodextrin in Pharmacy. Kluwer Academic Publishers: Dordrecht, The Netherlands (1994): Chapters 1 and 4-8.
- FUNASAKI N, UEMURA Y, HADA S, NEYA S: Reduction of the bitter taste intensity of propantheline bromide by cyclodextrins as predicted by surface tension measurements. J. Phys. Chem. (1996) 100:16298-16301.
- FUNASAKI N, KAWAGUCHI R, ISHIKAWA S, HADA S, NEYA S, KATSU T: Quantitative estimation of the bitter taste intensity of oxyphenonium bromide reduced by cyclodextrins from electromotive force measurements. Anal. Chem. (1999) 71:1733-1736.
- ANON: Taste masking β-lactam antibiotics with macroreticular resins. Res. Discl. (1978) 176:12-13.
- NANDA A, KANDAPARU R, GARG S: An update on taste masking technologies for oral pharmaceuticals. Indian J. Pharm. Sci. (2002) 64(1):10-17.
- MANEK SP, KAMAT VS: Evaluation of Indion CRP-244 and CRP-254 as sustained release and taste masking agents. Indian J. Pharm. Sci. (1981) 43:209-212.
- YAJIMA T, ITAI S, TAKEUCHI H, KAWASHIMA Y: Optimum heat treatment conditions for masking the bitterness of the clarithromycin wax matrix. Chem. Pharm. Bull. (2003) 51(11):1223-1226.
- YAJIMA T, UMEKI N, ITAI S: Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. Chem. Pharm. Bull. (1999) 47(2):220-225.
- MCGINITY JW, ZHANG F, REPKA M, KOLENG JJ: Hot-melt extrusion process as a pharmaceutical process. Am. Pharmaceut. Rev. (2001) 4:25-36.
Patents
- JOHN WYETH & BROTHER LIMITED: US4371516 (1983).
- R.P. SCHERER CORPORATION: US5631023 (1997).
- R.P. SCHERER CORPORATION: US5738875 (1998).
- CIMA LABS INC.: US5178878 (1993).
- CIMA LABS INC.: US6024981 (2000).
- CIMA LABS INC.: US5223264 (1993).
- CIMA LABS INC.: US5607697 (1997).
- CIMA LABS INC.: US6024981 (2000).
- R.P. SCHERER CORPORATION: US6156339 (2000).
- LABORATOIRES PROGRAPHARM: US5464632 (1995).
- YAMANOUCHI PHARMACEUTICAL CO. LTD: US5576014 (1996).
- ANTARES PHARMA IPL AG: US6696085 (2004).
- FERTIN FARMA AS: WO200213781 (2002).
- CIMA LABS INC.: US6221392 (2001).
- CIMA LABS INC.: WO2002096392 (2002).
- PFIZER PHARMA: WO9830209 (1998).
- GATTEFOSSE ETS SA: WO200207706 (2002).
- DAIICHI PHARMACEUTICALS LTD.: US6217910 (2001).
- ELAN COORPORATION PLC.: US6153220 (2000).
- EURAND AMERICA INC.: US5814332 (1998).
- EURAND AMERICA INC.: US5709886 (1998).
- EURAND AMERICA INC.: US6139865 (2000).
- NECTAR THERAPEUTICS UK LTD.: US7115280 (2006).
- CENTRE DE MICROENCAPSULATION: US6087003 (2000).
- THE ROLAND T, DODGE COMPANY: US5393533 (1995).
- THE ROLAND T, DODGE COMPANY: US5288504 (1994).
- PHOQUS PHARMACEUTICAL LTD.: WO2004017976 (2004).
- BRISTOL MYERS SQUIBB: US4916161 (1990).
- STROPPOLO F, CICCARELLO F, MILANI R, BELLORINI L: WO 2002/41920 (2002).
- UENO M: JP0411865 (1992).
- CYDEX INC.: US6046177 (2000).
- THE UPJOHN COMPANY: US4049700 (1997).
- UPJOHN MANUFACTURING COMPANY: US4361580 (1982).
- ASTRUC J, SAMBOT A: GB1180233 (1970).
- BORODKIN S, SUNDBERG DP: US3594470 (1971).
- AMERICAN CYANAMID CO.: GB2055575 (1981).
- ROUSSEL UCLAF: EP27768 (1981).
- GLAXO GROUP RESEARCH LTD: US5219563 (1990).
- ABBOTT LAB: EP0501763 (1992).
- WARNER LAMBERT COMPANY LLC.: US7067116 (2006).
- KV PHARMACEUTICAL COMPANY: US5494681 (1996).
- McNeil-PPC Inc.: US5429825 (1995).
- LAVIPHARM LAB INC.: WO200205820 (2002).
- ETHYPHARM INC.: US6649186 (2003).
- ETHYPHARM INC.: US6488961 (2002).
- ETHYPHARM INC.: US6071539 (2000).
- UNIVERSITY OF IOWA RESEARCH FOUNDATION: US6372259 (2002).
- RANBAXY LABORATORIES LTD.: US6565877 (2003).
Websites
- http://www.cardinal.com/pts/content/aboutus/whoweare/abourbro.asp Oral Technologies: Overview, Cardinal Health, Inc.
- http://www.rohacell.com/en/pharmapolymers-2.html Taste-Masking via Melt Extrusion Advantages (2004).